Merck & Co., Inc. (MRK)
NYSE · Manufacturing · Pharmaceutical preparations
MRK price, last 12 months
Key stats
- Previous close
- $137.78
- Open
- $139.17
- Day range
- $131.36 – $139.17
- 52-week range
- $93.90 – $156.92
- Volume
- 13.6M
- Avg volume (20 days)
- 9.2M
- Market cap
- $364.3B
Performance
Technicals and fundamentals
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $364.3B